MPO-IN-7 (compound MDC) is a myeloperoxidase inhibitor with the IC50 values of 41 µM, 25 µM and 4.5 µM towards alpha-Glucosidase, dipeptidyl peptidase-4 and myeloperoxidase, respectively. MPO-IN-7 shows antioxidant and anti-inflammatory activity in vitro[1].
